fashion -WSS

fashion

author：explore 2025-09-30 23:20:36 - browse：13493

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Will the IRA bring competition to the biologics market?

hotspot

WSS

It's time to take a new tack for treating Alzheimer's

The biotech scorecard for the 2nd quarter: 12 industry events to watch

FDA approves updated Covid vaccines

Private equity could exacerbate cardiology's overuse problem, experts fear

Generate Biomedicines machine learning biotech raises $273M

How Brent Saunders' Allergan experiment failed

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Generate Biomedicines machine learning biotech raises $273M

Medical records are filled with copy

WATCH: Why do bright lights make us see spots?

At least 13 dead in Texas as scorching temps continue

A common UTI test for kids haunts adults as a traumatic 'nightmare'

In age of alternative facts, a scholarly course on calling out crap

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Trump demands the U.S. pay no more for drugs than other countries … again

A former Republican legislative candidate has been charged for his role in the US Capitol riot

focus

EMA weighs against approval for Mirati's lung cancer drug

Popular nasal decongestant doesn't actually relieve congestion

Pig kidney works a record two months in donated body

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

New chart reveals military’s vast involvement in Operation Warp Speed

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

hotspot

Wikipedia

explore

Wikipedia